Zyversa Therapeutics Inc (ZVSA)

NASDAQ
Currency in USD
0.5180
-0.0218(-4.04%)
Closed·
After Hours
0.4816-0.0364(-7.027%)
·
ZVSA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual Post-Market activity
Fair Value
Day's Range
0.49600.5370
52 wk Range
0.47286.3000
Key Statistics
Edit
Prev. Close
0.5398
Open
0.518
Day's Range
0.496-0.537
52 wk Range
0.4728-6.3
Volume
386.61K
Average Volume (3m)
3.59M
1-Year Change
-89.95%
Book Value / Share
3.63
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZVSA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility
Show more

Zyversa Therapeutics Inc Company Profile

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial to the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, pancreatic cancer, Parkinson’s and Huntington’s disease, atherosclerosis, Alzheimer’s disease, and obesity. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.

Compare ZVSA to Peers and Sector

Metrics to compare
ZVSA
Peers
Sector
Relationship
P/E Ratio
−0.2x−3.3x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.2x1.8x2.6x
Price / LTM Sales
-27.2x2.9x
Upside (Analyst Target)
-229.9%53.0%
Fair Value Upside
Unlock−0.3%8.9%Unlock

Earnings

Latest Release
Apr 12, 2023
EPS / Forecast
-0.51 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

0.01
DMN
0.00%
0.03
PLRZ
-91.86%
0.0565
BON
-8.87%
6.250
RSLS
+3.99%

FAQ

What Is the Zyversa Therapeutics (ZVSA) Stock Price Today?

The Zyversa Therapeutics stock price today is 0.52

What Stock Exchange Does Zyversa Therapeutics Trade On?

Zyversa Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Zyversa Therapeutics?

The stock symbol for Zyversa Therapeutics is "ZVSA."

What Is the Zyversa Therapeutics Market Cap?

As of today, Zyversa Therapeutics market cap is 1.95M.

What Is Zyversa Therapeutics's Earnings Per Share (TTM)?

The Zyversa Therapeutics EPS (TTM) is -8.48.

From a Technical Analysis Perspective, Is ZVSA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.